Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine

Benjamin Young; Kathleen E. Squires; Karen Tashima; Keith Henry; Stefan Schneider; Anthony LaMarca; Henry H. Zhao; Lisa L. Ross; Mark S. Shaefer

doi:10.1179/1528433614Z.0000000017

Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine

Benjamin Young, Kathleen E. Squires, Karen Tashima, Keith Henry, Stefan Schneider, Anthony LaMarca, Henry H. Zhao, Lisa L. Ross, Mark S. Shaefer

Medicine - Infectious Disease and International

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	125-129
Number of pages	5
Journal	HIV Clinical Trials
Volume	16
Issue number	4
DOIs	https://doi.org/10.1179/1528433614Z.0000000017
State	Published - Aug 2015

Keywords

Antiretroviral therapy
GFR
Kidney function
Renal impairment

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1179/1528433614Z.0000000017

OpenUrl availability

Full text

Cite this

Young, B., Squires, K. E., Tashima, K., Henry, K., Schneider, S., LaMarca, A., Zhao, H. H., Ross, L. L., & Shaefer, M. S. (2015). Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine. HIV Clinical Trials, 16(4), 125-129. https://doi.org/10.1179/1528433614Z.0000000017

Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine. / Young, Benjamin; Squires, Kathleen E.; Tashima, Karen et al.
In: HIV Clinical Trials, Vol. 16, No. 4, 08.2015, p. 125-129.

Research output: Contribution to journal › Article › peer-review

Young, B, Squires, KE, Tashima, K, Henry, K, Schneider, S, LaMarca, A, Zhao, HH, Ross, LL & Shaefer, MS 2015, 'Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine', HIV Clinical Trials, vol. 16, no. 4, pp. 125-129. https://doi.org/10.1179/1528433614Z.0000000017

@article{1ca498a63b7d4a9aace4cfe26e1deb73,

title = "Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine",

keywords = "Antiretroviral therapy, GFR, Kidney function, Renal impairment",

author = "Benjamin Young and Squires, {Kathleen E.} and Karen Tashima and Keith Henry and Stefan Schneider and Anthony LaMarca and Zhao, {Henry H.} and Ross, {Lisa L.} and Shaefer, {Mark S.}",

year = "2015",

month = aug,

doi = "10.1179/1528433614Z.0000000017",

language = "English (US)",

volume = "16",

pages = "125--129",

journal = "HIV Clinical Trials",

issn = "1528-4336",

publisher = "Taylor and Francis Ltd.",

number = "4",

}

TY - JOUR

T1 - Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine

AU - Young, Benjamin

AU - Squires, Kathleen E.

AU - Tashima, Karen

AU - Henry, Keith

AU - Schneider, Stefan

AU - LaMarca, Anthony

AU - Zhao, Henry H.

AU - Ross, Lisa L.

AU - Shaefer, Mark S.

PY - 2015/8

Y1 - 2015/8

KW - Antiretroviral therapy

KW - GFR

KW - Kidney function

KW - Renal impairment

UR - http://www.scopus.com/inward/record.url?scp=84948389415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948389415&partnerID=8YFLogxK

U2 - 10.1179/1528433614Z.0000000017

DO - 10.1179/1528433614Z.0000000017

M3 - Article

AN - SCOPUS:84948389415

SN - 1528-4336

VL - 16

SP - 125

EP - 129

JO - HIV Clinical Trials

JF - HIV Clinical Trials

IS - 4

ER -

Estimated glomerular filtration rates through 144 weeks on therapy in HIV-1-infected subjects receiving atazanavir/ritonavir and abacavir/lamivudine or simplified to unboosted atazanavir/abacavir/lamivudine

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this